About The END Fund

ORGANIZATIONAL OVERVIEW

The END Fund is the world’s leading collaborative philanthropic investment vehicle dedicated to controlling and eliminating neglected tropical diseases (NTDs). NTDs are parasitic and bacterial infectious diseases – including intestinal worms, river blindness, trachoma, schistosomiasis and lymphatic filariasis – that affect over 1.7 billion people globally. The END Fund’s vision is to ensure people can live healthy and prosperous lives free of the risk of NTDs and has set out to accomplish this by:

  • Mobilizing and investing resources for maximum impact,
  • Advocating for innovative, integrated and cost-effective NTD programs; and
  • Facilitating philanthropic and private sector engagement to end these diseases.

By engaging a community of activist-philanthropists and taking a systems approach, the END Fund works in collaboration with governments, local and international NGOs, pharmaceutical companies, and academic partners on the global campaign to control and eliminate the most prevalent NTDs by 2030.

Since our founding in 2012 through 2019, with our partners, the END Fund has provided over 920 million treatments for NTDs worth more than $1 billion. In 2019 alone, we reached more than 121 million people with more than 196 million NTD treatments, representing an almost 10-fold increase from 2012. The END Fund works globally in over 25 countries, with a primary emphasis in Africa. You can read more about the END Fund and our 2019 impact story here.

OUR PHILOSOPHY AND BENEFITS

The END Fund is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. It is our policy and intent that all qualified persons be given full and equal opportunities for employment, training, promotions, wages, benefits, and all other privileges, terms, and conditions of employment.

The END Fund offers a competitive compensation package intended to motivate employees to perform at the highest level by acquiring superior skills and competencies to further the progress made to ensuring people with neglected tropical diseases can live healthy and prosperous lives. Our philosophy is shaped by the following guidelines: 1) understandable, 2) fair and defensible, 3) competitive, and 4) flexible. In addition to providing a competitive salary in the sector, we are proud to offer our employees 100% employer-paid health insurance benefits, 5% retirement contributions (without matching requirement), twelve weeks 100% paid parental leave, flexible work-from-home arrangements, a healthy annual professional development allowance, and more. Please note that benefits may vary by country of residency.

*In line with the END Fund’s core values, we are equally committed to responding to challenges swiftly and staying flexible with an unwavering dedication to reaching the best and most diverse candidate pool possible to further our mission. Given the social distancing restrictions due to COVID-19, our team is effectively working remotely through at least December 31, 2020. We are looking to on-board a candidate who is a self-starter, thrives in a dynamic, fast-paced environment, and is an excellent communicator. The END Fund strongly encourages all qualified candidates to apply.

 

  • Analyst, Program Evidence, Measurement & Evaluation (EME)

    The END Fund
    Anywhere
    • Full Time
    • Posted 9 months ago